Compare Aurora Cannabis Inc (ACB) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

Vipshop Holdings trades at $13.54, up 2.11% today, showing modest momentum despite a bearish technical signal. The stock presents compelling valuation metrics with a P/E of 6.08 and P/S of 0.43, well below sector averages. Recent Q1 2026 earnings matched expectations, while revenue trends show stabilization after a slight decline in 2025. Analyst sentiment remains positive with 53.57% buy ratings, though technical indicators suggest near-term caution.

The outlook for VIPS appears balanced between attractive valuation and operational challenges. The company's outlet strategy expansion and strong cash flow generation provide upside potential, but investors face risks from competitive pressures and China's economic headwinds. With solid profitability metrics and dividend payments, VIPS offers value characteristics but requires monitoring of revenue growth recovery.